EluPro Antibiotic-Eluting BioEnvelope Registry

Exclusion Criteria

• •Patient has a prior history of CIED infection, other prosthetic device infection, or endovascular infection, including endocarditis, in the past 12 months.
• •Patient is exhibiting signs or symptoms consistent with any type of active infection (including but not limited to pneumonia, urinary tract, cellulitis, or bacteremia).
• •Patient has Stage 4 or 5 kidney disease (eGFR \<30 ml/min).
• •Patient requires long-term vascular access for any reason.
• •Patient is undergoing implantation of a CIED that does not fit completely into EluPro, preventing closure of the bioenvelope to secure the CIED.
• •Patient is currently on chronic immunosuppressive agents or ≥20mg/day of Prednisone or equivalent.
• •Patient has known allergy to minocycline or rifampin or their derivatives, or any other known contraindications to the implantation of EluPro.
• •Patient is participating in another clinical study that could impact the outcome and documented pre-approval from the study sponsor has not been obtained.
• •Female patient who is pregnant, or of childbearing potential and not on a reliable form of birth control. Women of childbearing potential are required to have a negative pregnancy test within 7 days prior to device procedure.